Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
OnabotulinumtoxinA (Botox(®)): A Review of its Use in the Treatment of Urinary Incontinence in Patients with Multiple Sclerosis or Subcervical Spinal Cord Injury.
History, applications, and mechanisms of deep brain stimulation.
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
Correction: quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.
Teriflunomide (AUBAGIO). Multiple sclerosis: just a metabolite of leflunomide.
Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanism.
Effects of non-steroidal antiinflammatory drugs on D-serine-induced oxidative stress in vitro.
[Emerging therapies for multiple sclerosis.]
Evaluating treatment effect within a multivariate stochastic ordering framework: Nonparametric combination methodology applied to a study on multiple sclerosis.
Acute disseminated encephalomyelitis after tetanus vaccination of a pregnant woman in Senegal.
Pediatric Multiple Sclerosis.
Vitamin D in MS: A vitamin for 4 seasons.
Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression.
Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability.
Motivational interviewing may improve exercise experience for people with multiple sclerosis: A small randomized trial.
[Marihuana and cannobinoids as medicaments].
Riluzole.
Differences In Multiple Sclerosis Relapse Rates Based On Patient Adherence, Average Daily Dose, And Persistence With Disease-Modifying Therapy: Observations Based on Real-World Data.
Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes.
Cell intrinsic role of NF-κB-inducing kinase in regulating T cell-mediated immune and autoimmune responses.
Increased resistin levels in the serum and cerebrospinal fluid of patients with neuromyelitis optica.
Kinin-mediated inflammation in neurodegenerative disorders.
Alemtuzumab Therapy for Multiple Sclerosis.
Biochemical and antiviral activity of MK-0518, a potent HIV integrase inhibitor
Pages
« first
‹ previous
…
229
230
231
232
233
234
235
236
237
…
next ›
last »